Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Editor's Choice - Free Access

Male-to-Female Transsexualism: Technique, Results and 3-Year Follow-Up in 50 Patients

Wagner S. · Greco F. · Hoda M.R. · Inferrera A. · Lupo A. · Hamza A. · Fornara P.

Author affiliations

Clinic of Urology and Kidney Transplantation, Martin Luther University, Halle/Saale, Germany

Corresponding Author

Dr. Sigrid Wagner

Clinic of Urology and Kidney Transplantation, Martin Luther University

Ernst-Grube-Strasse 40

DE–06120 Halle/Saale (Germany)

Tel. +49 345 557 1674, Fax +49 345 557 4235, E-Mail sigrid.wagner@medizin.uni-halle.de

Related Articles for ""

Urol Int 2010;84:330–333

Do you have an account?

Login Information

Contact Information

By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.

I have read the Karger Terms and Conditions and agree.


Aim: To evaluate the functional and cosmetic results of male-to-female gender-transforming surgery. Patients and Methods: Between May 2001 and April 2008 we performed 50 male-to-female gender-transforming surgeries. All patients had been cross-dressing, living as women, and receiving estrogen and progesterone for at least 12 months, which was sufficient for breast development and atrophy of the testes and prostate to occur. This hormonal therapy was suspended 1 month before the operation. Results: The mean operative time was 190 min and the mean depth of the vagina was 10 cm. On follow-up, the most common complication (10%) was shrinkage of the neovagina, which could be corrected by a second surgical intervention. Of the 50 patients, 45 (90%) were satisfied with the esthetic results; 42 patients (84%) reported having regular sexual intercourse, 2 of whom had pain during intercourse. Of the 50 patients, 35 (70%) reported achieving clitoral orgasm. Conclusion: Male-to-female gender-transforming surgery can assure satisfactory cosmetic and functional results, with a reduced intra- and postoperative morbidity. Nevertheless the experience of the surgeon and the center remains central to obtaining optimal results.

© 2010 S. Karger AG, Basel


  1. Benjamin H: Transvestitism and transsexualism. Int J Sexol 1953;7:12–14.
  2. Soli M, Brunocilla E, Bertaccini A, Palmieri F, Barbieri B, Martorana G: Male to female gender reassignment: modified surgical technique for creating the neoclitoris and mons veneris. J Sex Med 2008;5:210–216.
  3. Jarolim L: Surgical conversion of genitalia in transsexual patients. BJU Int 2000;85:851–856.
  4. Krege S, Bex A, Lümmen G, Rübben H: Male-to-female transsexualism: a technique, results and long-term follow-up in 66 patients. BJU Int 2001;88:396–402.
  5. Goddard JC, Vickery RM, Terry TR: Development of feminizing genitoplasty for gender dysphoria. J Sex Med 2007;4:981–989.
  6. Selvaggi G, Ceulemans P, De Cuypere G, et al: Gender identity disorder: general overview and surgical treatment for vaginoplasty in male-to-female transsexuals. Plast Reconstr Surg 2005;116:135–145
    External Resources
  7. Sohn M, Bosinski HA: Gender identity disorders: diagnostic and surgical aspects. J Sex Med 2007;4:1193–1207.
  8. Goddard JC, Vickery RM, Qureshi A, Summerton DJ, Khoosal D, Terry TR: Feminizing genitoplasty in adult transsexuals: early and long-term surgical results. BJU Int 2007;100:607–613.
  9. Lawrence AA: Factors associated with satisfaction or regret following male-to-female sex reassignment surgery. Arch Sex Behav 2003;32:299–315.
  10. Lawrence AA: Patient-reported complications and functional outcomes of male-to- female sex reassignment surgery. Arch Sex Behav 2006;35:717–727.
  11. Rehman J, Melman A: Formation of neoclitoris from glans penis by reduction glansplasty with preservation of neurovascular bundle in male-to-female gender surgery: functional and cosmetic outcome. J Urol 1999;161:200–206.
  12. Perovic SV, Stanojevic SD, Djordjevic MLJ: Vaginoplasty in male transsexuals using penile skin and a urethral flap. BJU Int 2000;86:843–850.
  13. Barres BA: Does gender matter? Nature 2006;442:133–136.
  14. Stanojevic DS, Djordjevic ML, Milosevic A, et al: Sacrospinous ligament fixation for neovaginal prolapse prevention in male-to-female surgery. Urology 2007;70:767–771.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: July 06, 2009
Accepted: October 26, 2009
Published online: April 13, 2010
Issue release date: April 2010

Number of Print Pages: 4
Number of Figures: 5
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.